DLCIG
ABBV icon

D.L. Carlson Investment Group’s AbbVie ABBV Stock Holding History

D.L. Carlson Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,690
Closed -$1.83M – 151
2019
Q1 		$1.83M Sell
22,690
-1,200
-5% -$98.2K 0.53% 70
2018
Q4 		$2.2M Hold
23,890
– – 0.73% 53
2018
Q3 		$2.26M Sell
23,890
-82
-0.3% -$7.78K 0.64% 64
2018
Q2 		$2.22M Buy
23,972
+140
+0.6% +$13.7K 0.68% 60
2018
Q1 		$2.26M Sell
23,832
-3,000
-11% -$330K 0.71% 59
2017
Q4 		$2.6M Hold
26,832
– – 0.77% 53
2017
Q3 		$2.38M Sell
26,832
-27,676
-51% -$2.11M 0.74% 57
2017
Q2 		$3.95M Buy
54,508
+25,811
+90% +$1.74M 1.16% 34
2017
Q1 		$1.87M Hold
28,697
– – 0.63% 67
2016
Q4 		$1.8M Sell
28,697
-83
-0.3% -$5.07K 0.61% 71
2016
Q3 		$1.81M Hold
28,780
– – 0.63% 67
2016
Q2 		$1.78M Hold
28,780
– – 0.64% 70
2016
Q1 		$1.64M Sell
28,780
-510
-2% -$28.4K 0.61% 66
2015
Q4 		$1.74M Buy
29,290
+640
+2% +$36.9K 0.65% 65
2015
Q3 		$1.56M Hold
28,650
– – 0.63% 67
2015
Q2 		$1.93M Hold
28,650
– – 0.7% 63
2015
Q1 		$1.68M Sell
28,650
-1,608
-5% -$97.1K 0.6% 71
2014
Q4 		$1.98M Sell
30,258
-100
-0.3% -$6.3K 0.71% 59
2014
Q3 		$1.75M Buy
30,358
+228
+0.8% +$12.7K 0.66% 63
2014
Q2 		$1.7M Sell
30,130
-400
-1% -$21K 0.62% 66
2014
Q1 		$1.57M Sell
30,530
-77,537
-72% -$3.92M 0.59% 68
2013
Q4 		$5.71M Sell
108,067
-2,448
-2% -$120K 2.08% 6
2013
Q3 		$4.94M Sell
110,515
-5,855
-5% -$260K 1.9% 10
2013
Q2 		$4.81M Buy
+116,370
New +$5.09M 1.93% 8

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

D.L. Carlson Investment Group's ABBV Position: Q2 2019 in Review

D.L. Carlson Investment Group sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 22,690 shares — an estimated $1.83M sold.

D.L. Carlson Investment Group first reported a position in ABBV in Q2 2013 and held it in 24 quarters. The position peaked at $5.71M in Q4 2013. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • D.L. Carlson Investment Group reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 22,690 AbbVie shares in Q2 2019, an estimated $1.83M.
  • D.L. Carlson Investment Group first reported a position in AbbVie in Q2 2013 and held it in 24 quarters.
  • D.L. Carlson Investment Group's AbbVie position peaked at $5.71M in Q4 2013.
  • 2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2019, filed 19 Aug 2019.